Skip to main content
New Year’s Sale — Build a balanced news diet with 40% off Vantage
Get Started
SubscribeLogin
Published • loading... • Updated

Migraine and arthritis drugs drop to $299 a month under new Amgen plan

Summary by stocktitan.net
Amgen expands its AmgenNow program, adding $299 Aimovig and Amjevita plus $239 Repatha, while investing $2.5B in new U.S. manufacturing sites.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

stocktitan.netstocktitan.net

Migraine and arthritis drugs drop to $299 a month under new Amgen plan

Amgen expands its AmgenNow program, adding $299 Aimovig and Amjevita plus $239 Repatha, while investing $2.5B in new U.S. manufacturing sites.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news in on Friday, December 19, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Amgen icon

Amgen

United States icon

United States

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal